Effects of short-term caloric restriction on circulating free IGF-I, acid-labile subunit, IGF-binding proteins (IGFBPs)-1-4, and IGFBPs-1-3 protease activity in obese subjects

European Journal of Endocrinology

Volumn 155, Issue 4, 2006, Pages 575-581

  Rasmussen, Michael Højby ^a,b   Juul, Andres ^a   Kjems, Lise Lund ^a   Hilsted, Jannik ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NONE   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACID LABILE SUBUNIT; GROWTH HORMONE; PROTEINASE; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CALORIC RESTRICTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HORMONE RELEASE; HUMAN; IMMUNORADIOMETRIC ASSAY; LEAN BODY WEIGHT; LOW CALORY DIET; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN DEGRADATION; SHORT COURSE THERAPY; WEIGHT REDUCTION;

ADULT; BODY MASS INDEX; BODY WEIGHT; CALORIC RESTRICTION; CARRIER PROTEINS; DIET, REDUCING; ENDOPEPTIDASES; FEMALE; GLYCOPROTEINS; HUMAN GROWTH HORMONE; HUMANS; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 2; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 4; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; LEPTIN; MALE; OBESITY; PROTEIN DENATURATION; THINNESS; TIME FACTORS; WEIGHT LOSS;

EID: 33750241559     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.1.02246     Document Type: Article

References (38)

1. Rasmussen MH, Hvidberg A, Juul A, Main KM, Gotfredsen A, Skakkebaek NE & Hilsted J. Massive weight loss restores 24-h growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects. Journal of Clinical Endocrinology and Metabolism 1995 80 1407-1415.
2. De Marinis L, Bianchi A, Mancini A, Gentiella R, Perrelli M, Giampietro A, Porcelli T, Tilaro, L, Fusco A, Valle D & Tacchino RM. Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition. Journal of Clinical Endocrinology and Metabolism 2004 89 174-180.
3. Engstrom BE, Burman P, Holdstock C, Öhrval M, Sundbom M & Karlsson FA. Effects of gastric bypass on the GH/IGF-I axis in severe obesity - and a comparison with GH deficiency. European Journal of Endocrinology 2006 154 53-59.
4. Frystyk J, Skjaerbaek C, Vestbo E, Fisker A & Ørskov H. Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metabolism Research and Reviews 1999 15 314-322.
5. Nyomba BLG, Johnson M, Berard L & Murphy LJ. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 1999 48 840-844.
6. Gomez JM, Maravall FJ, Gomez N, Navarro MA, Casamitjana R & Soler J. The IGF-I system component concentrations that decrease with ageing are lower in obesity in relationship to body mass index and body fat. Growth Hormone and IGF Research 2004 14 91-96.
7. Rasmussen MH, Juul A, Kjems LL, Skakkebaek NE & Hilsted J. Lack of stimulation of 24-h growth hormone release by hypocaloric diet in obesity. Journal of Clinical Endocrinology and Metabolism 1995 80 796-801.
8. Grottoli S, Gauna C, Tassone F, Aimaretti G, Corneli G, Wu Z, Strasburger CJ, Diequez C, Casanneva FF, Ghigo E & Maccario M. Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity. Clinical Endocrinology 2003 58 220-228.
9. Daughaday WH. Free insulin-like growth factor (IGF) in disorders of IGF binding protein 3 complex formation. Journal of Clinical Endocrinology and Metabolism 2004 89 3-5.
10. Juul A. Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Hormone and IGF Research 2003 13 113-170.
11. Bang P, Nygren J, Carlsson-Skwirut C, Thorell A & Ljungqvist O. Postoperative induction of insulin like growth factor binding protein-3 proteolytic activity, relation to insulin and insulin sensitivity. Journal of Clinical Endocrinology and Metabolism 1998 83 2509-2515.
12. Soderberg S, Ahren B, Eliasson M, Dinesen B, Brismar K & Olsson T. Circulating IGF binding protein-1 is inversely associated with leptin in non-obese men and obese postmenopausal women. European Journal of Endocrinology 2001 144 283-290.
13. Liew CF, Wise SD, Yen KP & Lee KO. Insulin-like growth factor binding protein-1 is independently affected by ethnicity, insulin sensitivity, and leptin in healthy, glucose-tolerant young men. Journal of Clinical Endocrinology and Metabolism 2005 90 1483-1488.
14. Lamson G, Giudice LC & Rosenfeld RG. A simple assay for protcolysis of IGFBP-3. Journal of Clinical Endocrinology and Metabolism 1991 72 1391-1393.
15. Hossenlopp P, Seurin B, Segovia-Quinnson B, Hardouin S & Binoux M. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Annals of Biochemistry 1986 154 138-143.
16. Khosravi MJ, Diamandi A, Mistry J, Krishna RG & Khare A. Acid-labile subunit of human insulin-like growth factor-binding protein complex: measurement, molecular, and clinical evaluation. Journal of Clinical Endocrinology and Metabolism 199 7 82 3944-3951.
17. Meriam GR & Watcher KW. Algorithms for the study of episodic hormone secretion. American Journal of Physiology 1982 243 E310-E318.
18. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF & Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985 28 412-419.
19. Levy JC, Matthews DR & Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998 21 2191-2192.
20. Ho KY, Veldhuis JD, Johnson MI, Furlanetto R, Evans WS, Alberti KG & Thorner MO. Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. Journal of Clinical Investigation 1998 81 968-975.
21. Jones JI & Clemmons DR. Insulin-like growth factors and their binding proteins: biological actions. Endocrine Reviews 1995 16 3-34.
22. Frystyk J, Skjærbæk C, Dinesen B & Örskov H. Free insulin-like growth factors (IGF-I and IGF-II) in human serum. FEBS Letters 1994 348 185-191.
23. Fowlkes JL. Insulin-like growth factor binding protein proteolysis. Trends in Endocrinology and Metabolism 1997 8 299-306.
24. Maccario M, Tassone F, Gianotti L, Lanfranco F, Grottoli S, Arvat E, Muller EE & Ghigo E. Effects of recombinant human insulin-like growth factor I administration on the growth hormone (GH) response to GH-releasing hormone in obesity. Journal of Clinical Endocrinology and Metabolism 2001 86 167-171.
25. Clemmons DR, Snyder DK & Busby WH. Variable controlling the secretion of insulin-like growth factor binding-2 in normal human subjects. Journal of Clinical Endocrinology and Metabolism 1991 73 727-878.
26. Frystyk J. Free insulin-like growth factors - measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Hormone and IGF Research 2004 14 337-375.
27. Zhou R, Diehl D, Hoeflich A, Lahm H & Wolf E. IGF-binding protein-4: biochemical characteristics and functional consequences. Journal of Endocrinology 2003 2 177-193.
28. Juul A, Flyvbjerg A, Frystyk I, Müffler J & Skakkebæk NE. Serum concentrations of free and total insulin-like growth factor-1, IGF binding proteins -1 and -3 and IGFBP-3 protease activity in boys with normal or precocious puberty. Clinical Endocrinology 1996 44 515-523.
29. Frystyk J, Vestbo E, Skjærbæk C, Mogensen CE & Örskov H. Free insulin-like growth factors in human obesity. Metabolism 1995 44 37-44.
30. Nam SY, Lee EJ, Kim KR, Cha BS, Song YD, Lim SK, Lee HC & Hub KB. Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1,IGFBP-2, IGFBP-3, insulin, and growth hormone. International Journal of Obesity and Related Metabolic Disorders 1997 21 355-359.
31. Nyomba BLG, Johnson M, Berard L & Murphy LJ. Relationship between serum leptin and the insulin-like growth factor-I system in humans. Metabolism 1999 48 840-844.
32. Fernandez-Real IM, Pugeat M, Emptoz-Bonneton A & Richart W, Study of the effect of changing glucose, insulin, and insulin-like growth factor levels on serum corticosteroid binding globulin in lean, obese and obese subjects with glucose intolerance. Metabolism 2001 50 1248-1252.
33. Espelund U, Bruun JM, Richelsen B, Flyvbjerg A & Frystyk J. Pro- and mature IGF-II during diet- induced weight loss in obese subjects. European Journal of Endocrinology 2005 153 861-869.
34. Fors H, Matsuoka H, Bosaeus I, Rosberg S, Albertsson-Wickland K & Bjarnason R. Serum leptin levels correlate with growth hormone secretion and body fat in children. Journal of Clinical Endocrinology and Metabolism 1999 84 3586-3590.
35. Ozata M, Diequez C & Casanueva FF. The inhibition of growth hormone secretion presented in obesity is not mediated by the high leptin levels, a study in human leptin deficiency patients. Journal of Clinical Endocrinology and Metabolism 2003 88 312-316.
36. Rosenbaum M, Goldschmidt R, Bloomfield D, Magnano A, Weimar L, Heymsfield S, Gallagher D, Mayer L, Murphy E & Leibel RL. Low-dose leptin reverses skeletal muscle, autonomic, and neuroendocrine adaptions to maintenance of reduced weight. Journal of Clinical Investigation 2005 115 3579-3586.
37. Sandhu MS, Heald AH, Gibson JM, Cruickshank JK, Dunger DB & Warreham NJ. Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study. Lancet 2002 359 1740-1745.
38. Juul A, Scheike T, Davidsen M, Gyllenborg J & Jørgensen T. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease. Circulation 2002 106 939-944.